Utilization of an ex vivo human placental perfusion model to predict potential fetal exposure to carboplatin during pregnancy

Doses of carboplatin up to an area under the curve of 7.5 were not associated with significant placental transfer, fetal exposure, or fetal toxic effects. This suggests it might not be necessary to empirically reduce carboplatin doses in pregnant women.